1. Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
   Qingfan Yang et al, 2022, Frontiers in Oncology CrossRef
2. Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy
   Nilanjan Adhikari et al, 2021, Journal of Medicinal Chemistry CrossRef
3. MicroRNAs are involved in the development and progression of gastric cancer
   Xiaolin Liu et al, 2021, Acta Pharmacologica Sinica CrossRef
4. CHD3/4/5/6/8 serve as potential prognostic predictors in human gastric cancer
   Lijun Xu et al, 2021, Network Modeling Analysis in Health Informatics and Bioinformatics CrossRef
5. Discovery of Novel HDAC3 Inhibitors with PD-L1 Downregulating/Degrading and Antitumor Immune Effects
   Zhiqiang Sun et al, 2024, Journal of Medicinal Chemistry CrossRef
6. The Role of miRNA-132 against Apoptosis and Oxidative Stress in Heart Failure
   Xuelei Liu et al, 2018, BioMed Research International CrossRef
7. Clinical significance of HDAC1, -2 and -3 expression levels in esophageal squamous cell carcinoma
   Huiwu Li et al, 2020, Experimental and Therapeutic Medicine CrossRef
8. miR‑454 promotes survival and induces oxaliplatin resistance in gastric carcinoma cells by targeting CYLD
   Chaoqun Huang et al, 2020, Experimental and Therapeutic Medicine CrossRef
9. The Relationship between Histone Deacetylase (HDACs) and Gastric Cancer
   珊 徐, 2020, Advances in Clinical Medicine CrossRef
10. Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors
    Goverdhan Lanka et al, 2023, Computers in Biology and Medicine CrossRef